Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products in North America. The company engages in the commercialization of plant-based MyCell technology delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of the valuable compounds. The company has the exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K, and iron. It also engages in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts that makes fat-soluble substances available for immediate absorption into the body reach near 100% bioavailability and water compatibility. The company was founded in 1988 and is headquartered in Toronto, Canada.
Stock data | 2024 | Change |
---|---|---|
Price | $0.0403981049616218 | N/A |
Market Cap | $2.31M | N/A |
Shares Outstanding | 57.11M | N/A |
Employees | 0 | N/A |